Investigational Site Number 840101
Boston, Massachusetts 02115
0 studies enrolling now · 2 studies all time
What they study most
Neoplasm Malignant
Studies at this site
Phase 1 Safety Testing of SAR405838
— Completed
A Phase I/Ib Trial for the Evaluation of SAR260301 in Monotherapy or in Combination With Vemurafenib in Patients With Various Advanced Cancer
— Completed